MiR-130a-3p inhibits endothelial inflammation by regulating the expression of MAPK8 in endothelial cells

Mingming Gu1, Kun Liu1, Hui Xiong1

  • 1Department of Cardiothoracic Surgery, Affiliated Hospital of Nantong University, Nantong, 226001, Jiangsu Province, China.

Heliyon
|February 1, 2024
PubMed

Insights

MicroRNA-130a-3p (miR-130a-3p) protects against atherosclerosis by promoting endothelial cell proliferation and reducing inflammation. Upregulating miR-130a-3p counteracts the effects of oxidized LDL, suggesting it as a therapeutic target.

Area of Science:

  • Molecular Biology
  • Cardiovascular Research
  • Cell Biology

Background:

  • Atherosclerosis (AS) is a chronic inflammatory disease.
  • Endothelial cell dysfunction is a key factor in AS pathogenesis.
  • MicroRNAs play crucial roles in regulating cellular processes relevant to AS.

Purpose of the Study:

  • To investigate the role of microRNA-130a-3p (miR-130a-3p) in endothelial cells (ECs) exposed to oxidized low-density lipoprotein (ox-LDL).
  • To explore the underlying molecular mechanisms of miR-130a-3p in ox-LDL-treated ECs.
  • To evaluate the therapeutic potential of miR-130a-3p in AS.

Main Methods:

  • Human umbilical vein endothelial cells (HUVECs) were treated with ox-LDL.
  • Cell proliferation and apoptosis were assessed using CCK-8, EdU, and flow cytometry.
  • Cytokine expression and protein levels were measured by ELISA and Western blot.
  • Bioinformatics and dual-luciferase reporter assays identified MAPK8 as a direct target of miR-130a-3p.

Main Results:

  • miR-130a-3p was downregulated in ox-LDL-treated HUVECs.
  • Upregulation of miR-130a-3p promoted HUVEC proliferation and inhibited apoptosis.
  • miR-130a-3p suppressed inflammatory markers (TNF-α, IL-6) and adhesion molecules (VCAM-1, ICAM-1, E-selectin).
  • MAPK8 was upregulated by ox-LDL; its silencing mimicked miR-130a-3p's protective effects.

Conclusions:

  • miR-130a-3p exerts protective effects on endothelial cells against ox-LDL-induced injury.
  • miR-130a-3p targets MAPK8, mediating its anti-inflammatory and anti-apoptotic functions.
  • miR-130a-3p represents a promising therapeutic target for atherosclerosis treatment.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.5K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.6K